The Scientific Advisory Team at Ashvattha Therapeutics provides expert guidance and consultation on the development and clinical strategy of hydroxyl dendrimer therapeutics. This team of advisors leverages their extensive knowledge in oncology, ophthalmology, and inflammatory diseases to ensure the scientific robustness and innovation of Ashvattha’s therapeutic programs.
View all